Evidence map›Paper›PMID 27337340›Full record

ArticleNature2016

A complement-microglial axis drives synapse loss during virus-induced memory impairment.

Michael J Vasek, Charise Garber, Denise Dorsey, Douglas M Durrant, Bryan Bollman, Allison Soung, Jinsheng Yu, Carlos Perez-Torres, Arnaud Frouin, Daniel K Wilton and 12 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 422 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
422citing papers in PubMed, 3 pooled it
33.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

422 citing papers in PubMed, 3 syntheses or guidelines pooled it, 666 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Synthetic viral RNA mimetics induce neuronal loss through microglial phagocytosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  6. Article
  7. Review
  8. Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States.medRxiv : the preprint server for health sciences · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

362 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 1 country.

Michael J VasekDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Charise GarberDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Denise DorseyDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Douglas M DurrantDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Bryan BollmanDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Allison SoungDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Jinsheng YuDepartment of Genetics, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Carlos Perez-TorresDepartment of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Arnaud FrouinDepartment of Neurology, F. M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Daniel K WiltonDepartment of Neurology, F. M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Kristen FunkDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Bette K DeMastersDepartment of Neurology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.
Xiaoping JiangDepartment of Psychiatry, Washington University School of Medicine, St Louis, Missouri 63110, USA.
James R BowenDepartment of Pediatrics and Children's Healthcare of Atlanta, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia 30329, USA.
Steven MennerickDepartment of Psychiatry, Washington University School of Medicine, St Louis, Missouri 63110, USA.
John K RobinsonDepartment of Psychology, Stony Brook University, Stony Brook, New York 11794, USA.
Joel R GarbowDepartment of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Kenneth L TylerDepartment of Neurology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.
Mehul S SutharDepartment of Pediatrics and Children's Healthcare of Atlanta, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia 30329, USA.
Robert E SchmidtDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Beth StevensDepartment of Neurology, F. M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Robyn S KleinDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Washington University in St. Louis · USHarvard University · USEmory University · USUniversity of Colorado Denver · USStony Brook University · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
West Nile Virus and host control of innate defensesU19AI083019 · NIAID · UNIVERSITY OF WASHINGTON · PI CLARK, EDWARD A · 2009 to 2018
$22.5M
TAM Receptors and Virus InfectionR01AI101400 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI DIAMOND, MICHAEL S, KLEIN, ROBYN S. · 2012 to 2021
$5.8M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SAHIN, MUSTAFA · 2016 to 2020
$5.2M
Neuroprotection and repair during West Nile Virus EncephalitisR01NS052632 · NINDS · WASHINGTON UNIVERSITY · PI KLEIN, ROBYN S. · 2005 to 2020
$5.0M
Molecular Pathogenesis of Infectious DiseasesT32AI052066 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2002 to 2022
$2.3M
ALTERATIONS IN ADULT NEUROGENESIS DURING WEST NILE VIRUS ENCEPHALITISF31NS077640 · NINDS · WASHINGTON UNIVERSITY · PI VASEK, MICHAEL JOHN · 2012 to 2013
$55k
NCI NIH HHS P30 CA091842NIAID NIH HHS R01 AI101400NIAID NIH HHS T32 AI052066NIAID NIH HHS U19 AI083019NICHD NIH HHS U54 HD090255NINDS NIH HHS F31 NS077640NINDS NIH HHS R01 NS052632
6 · The paper itself

Abstract

Over 50% of patients who survive neuroinvasive infection with West Nile virus (WNV) exhibit chronic cognitive sequelae. Although thousands of cases of WNV-mediated memory dysfunction accrue annually, the mechanisms responsible for these impairments are unknown. The classical complement cascade, a key component of innate immune pathogen defence, mediates synaptic pruning by microglia during early postnatal development. Here we show that viral infection of adult hippocampal neurons induces complement-mediated elimination of presynaptic terminals in a murine WNV neuroinvasive disease model. Inoculation of WNV-NS5-E218A, a WNV with a mutant NS5(E218A) protein leads to survival rates and cognitive dysfunction that mirror human WNV neuroinvasive disease. WNV-NS5-E218A-recovered mice (recovery defined as survival after acute infection) display impaired spatial learning and persistence of phagocytic microglia without loss of hippocampal neurons or volume. Hippocampi from WNV-NS5-E218A-recovered mice with poor spatial learning show increased expression of genes that drive synaptic remodelling by microglia via complement. C1QA was upregulated and localized to microglia, infected neurons and presynaptic terminals during WNV neuroinvasive disease. Murine and human WNV neuroinvasive disease post-mortem samples exhibit loss of hippocampal CA3 presynaptic terminals, and murine studies revealed microglial engulfment of presynaptic terminals during acute infection and after recovery. Mice with fewer microglia (Il34(-/-) mice with a deficiency in IL-34 production) or deficiency in complement C3 or C3a receptor were protected from WNV-induced synaptic terminal loss. Our study provides a new murine model of WNV-induced spatial memory impairment, and identifies a potential mechanism underlying neurocognitive impairment in patients recovering from WNV neuroinvasive disease.

Indexed as

Neuronal PlasticityAnimalsCA3 Region, HippocampalComplement ActivationComplement Pathway, ClassicalComplement System ProteinsDisease Models, AnimalFemaleHumansMaleMemory DisordersMiceMicrogliaNeuronsPresynaptic TerminalsSpatial MemoryComplement System Proteins

Identifiers

PMID27337340
PMCPMC5452615
OpenAlexW2471701648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.